David A. Scheinberg is an American physician, scientist, drug developer, and entrepreneur, who is Vincent Astor Chair, Chair of the Center for Experimental Therapeutics and former Chair of the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center (MSK).
[2][3] Scheinberg received a BA from Cornell University and an MD, PhD from Johns Hopkins University School of Medicine.
In 2013 Nature Biotechnology recognized him as one of the top 20 Translational Scientists in the world.
[4] Scheinberg has published more than 350 papers, chapters, or books and has more than 40 patents.
His laboratory studies cancer immunology, cellular engineering, cancer vaccines, T cell receptor mimic antibodies, and targeted nano-machines.